Skip to main content
Clinical Trials/NCT00518128
NCT00518128
Completed
Not Applicable

Measuring Effectiveness in Sleep Apnea Surgery

University of California, San Francisco1 site in 1 country60 target enrollmentJuly 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obstructive Sleep Apnea
Sponsor
University of California, San Francisco
Enrollment
60
Locations
1
Primary Endpoint
C-reactive protein level
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

The goal of this research is to improve our understanding of the effectiveness of surgical OSA treatment by evaluating its impact on these health-related and functional outcomes and comparing these effects to the changes in respiratory physiology achieved after surgery. To achieve this goal, we will examine key health-related (C-reactive protein, homocysteine, leptin, the homeostasis model of insulin resistance, and heart rate variability) and functional (sleep-related quality of life and vigilance) measures among a surgical group of OSA patients who do not tolerate non-surgical treatment (positive airway pressure, PAP) and a comparison group of matched OSA patients who tolerate PAP.

Detailed Description

The goal of this research is to improve our understanding of the effectiveness of surgical OSA treatment by evaluating its impact on these health-related and functional outcomes and comparing these effects to the changes in respiratory physiology achieved after surgery. To achieve this goal, we will examine key health-related (C-reactive protein, homocysteine, leptin, the homeostasis model of insulin resistance, and heart rate variability) and functional (sleep-related quality of life and vigilance) measures among a surgical group of OSA patients who do not tolerate non-surgical treatment (positive airway pressure, PAP) and a comparison group of matched OSA patients who tolerate PAP. We propose to measure the impact of surgical OSA treatment on these health-related and functional outcomes measures with the following three analyses: (1) to assess the changes seen with surgical treatment; (2) to compare changes seen with surgical and PAP treatment; and (3) to evaluate the association between changes in respiratory patterns during sleep and changes in health-related and functional outcomes measures for both surgical and PAP treatment.

Registry
clinicaltrials.gov
Start Date
July 2007
End Date
June 2011
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Eric Kezirian

Associate Professor, Department of Otolaryngology--Head and Neck Surgery

University of California, San Francisco

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Pregnant women
  • Primary snoring or mild OSA (apnea-hypopnea index \< 15)
  • Known neurologic, cardiac, hepatic, or renal disorder
  • Acute illness or infection
  • Co-existing sleep disorder other than primary snoring
  • Unable to fast overnight prior to blood draw

Outcomes

Primary Outcomes

C-reactive protein level

Time Frame: Before and after surgery

Secondary Outcomes

  • Leptin, Homocysteine, Homeostasis model of insulin resistance (HOMA-IR), Heart rate variability, Functional Outcomes of Sleep Questionnaire and Psychomotor Vigilance Task.(Before and after surgery)

Study Sites (1)

Loading locations...

Similar Trials